Opinion: STAT+: BIO CEO: American biotech needs a coordinated plan to beat China — now
China just announced a new five-year plan that designates biotechnology as a national “pillar industry” and aims to displace the United States as the world’s biotech leader.
Key points
- It fuels advanced manufacturing growth, ensures our loved ones have access to the newest and most groundbreaking medicines, and strengthens our defenses against pandemics and biological threats.
- America’s biotech sector supports nearly 10 million jobs and over $3 trillion in annual economic activity.
- Losing our biotech lead would mean losing a pillar of both our economy and our national security.
Yet biotech innovation also depends on numerous interconnected players — from the university laboratories and startups that often pioneer new research to the trial networks and manufacturing facilities that bring medicines to patients.
Instead, we need a plan that strengthens every facet of our biotech ecosystem.
Additional details
- Continue to STAT+ to read the full story….
- Those ambitions threaten one of America’s defining competitive advantages — and they demand an urgent response.
- That means there’s no single policy that will protect our lead.
How this summary was made: extractive summary — built from the sources' own reporting. It is drawn only from the reporting of the sources listed below — read the originals for full detail. How we summarize →
Advertisement
Every article behind this summary — 1 article from 1 outlet
Get stories like this in your inbox.
Subscribe — it's freeOne free email at 6am — your topics, deduplicated, five minutes. No account, no paywall.